Financial Analysis and Valuation of Hawkins Inc. by Alvarado, Samantha
Minnesota State University Moorhead 
RED: a Repository of Digital Collections 
Dissertations, Theses, and Projects Graduate Studies 
Winter 12-19-2019 
Financial Analysis and Valuation of Hawkins Inc. 
Samantha Alvarado 
samantha.alvarado@go.mnstate.edu 
Follow this and additional works at: https://red.mnstate.edu/thesis 
Recommended Citation 
Alvarado, Samantha, "Financial Analysis and Valuation of Hawkins Inc." (2019). Dissertations, Theses, and 
Projects. 294. 
https://red.mnstate.edu/thesis/294 
This Project (696 or 796 registration) is brought to you for free and open access by the Graduate Studies at RED: a 
Repository of Digital Collections. It has been accepted for inclusion in Dissertations, Theses, and Projects by an 
authorized administrator of RED: a Repository of Digital Collections. For more information, please contact 
RED@mnstate.edu. 
Hawkins, Inc. (HWKN) MSUM Paseka School of Business 11/1/2019 
P a g e  1 | 20 
 
Hawkins, Inc. 
HWKN / NASDAQ 
Initiating Coverage      
Investment Rating: Sell 
 
PRICE: USD 43.56 S&P 500: 3,066.91 DIJA: 27,347.36 RUSSELL 2000: 1,589.33 
  
• Hawkins, Inc. declared a quarterly cash dividend of USD 0.23 per share (USD 2.45 million) 
on October 31, 2019 
• Hawkins entered the Health and Nutrition market with the acquisition of Stauber Specialty 
Ingredients in 2015 – its largest acquisition in the company’s history 
• The newest addition to Hawkins’ product line is a series of beer souring agents curated by 
Hawkins themselves 
 
Valuation 2019 A 2020 E 2021 E 
EPS (USD) $2.75 $3.66 $3.86 
P/E 17.24 10.86 10.93 
P/CFPS 8.23 8.53 8.52 
P/BVPS 27.77 28.01 28.62 
EV/EBITDA 8.53 10.77 9.73 
*The actual figures in this chart are from Yahoo!Finance as of November 1, 2019 
Market and Trading Information   
Equity Market Cap (USD) (M): 468.598 52-Week Range (USD): 32.79 - 47.94 
Enterprise Value (USD)(M): 543.09 12-Month Stock Return: 36.17% 
Shares Outstanding (M): 10.58 Dividend / Capital Gain Yields 2.31/33.86% 
Estimated Float (M): 9.57 12-Month Russell 2000 Return: 6.73% 
3-mo Avg. Daily Volume (M): 87,401 Beta: 1.07 
 
Company Quick View: 
Location:  2381 Rosegate, Roseville MN, 55113 
Industry:  Chemicals and allied products, SIC 5169 / Other Chemical and Allied Products Merchant 
Wholesaler, NAICS 424690 
Description:  Hawkins, Inc. distributes, blends and manufactures bulk and specialty chemicals and 
other health and nutrition products for its customers in a wide variety of industries. Headquartered 
in Roseville, Minnesota, and with 41 facilities in 19 states, the Company creates value for its 
customers through superb customer service and support, quality products and personalized 
applications 
Key Products & Services:  Industrial, Water Treatment, Health and Nutrition  
Website: http://www.hawkinsinc.com  
 
Analyst: Samantha Alvarado  
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STOCK PRICE PERFORMANCE 
Figure 1: 5-year Stock Price Performance 
 
Hawkins, Inc. (HWKN) closed on the NASDAQ at USD 43.56 per share on November 1, 2019.  
The stock took a sharp turn downwards during October 2019, but has made a recovery as the 
company released its rosy second quarter reports.  The 52-week range of the stock is USD 32.79 
– 47.94.   Year-to-date, Hawkins has had a return of 5.73 percent, while its closest industry 
competitor, Innophos Holdings, has earned a return of 37.30 percent.  From November 1, 2018 to 
this report date, the company stock has seen a return of 18.54 percent.  Hawkins earned a higher 
return than Innophos Holdings and the Russell 2000 with 12-month return of 11.44 percent and 
4.28 percent, respectively.  Hawkins’ five-year annual return is 2.89 percent, which is above 
Innophos Holdings’ return of -1.88 percent.  The Russell 2000 has a return of 8.93 percent over 
the same time.  Hawkins, Inc. has a history of outperforming the return of its competitors, 
however, has fallen short of Innophos’ growth since January.   
  
INVESTMENT DECISION SUMMARY 
Using a corporate valuation model that discounts free cash flows at the average cost of funding 
(WACC), I have forecasted an intrinsic value as of 11/1/2019 of USD 33.79.  Given the current 
economic conditions, the sales growth of the company has softened. However, their most recent 
quarterly report has shown that their gross profit margins have improved slightly over previous 
years due to favorable pricing in the commodities markets.  Their mix of debt and equity 
financing is the driving factor behind the lower intrinsic value than market.  Only 15 percent of 
the firm is financed with debt, and 85 percent of the firm is financed through equity.  Equity is 
the more costly financing at 9.42 percent.  After conducting this analysis, I recommend that 
investors sell Hawkins, Inc. stock because the intrinsic value of the stock I have forecasted is 
more than 10 percent below the market price.  While this price is within the 52-week range, the 
standard deviation of the monthly returns of the stock is 9 percent, and the intrinsic value I 
calculated is more than one standard deviation from the mean return. 
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Hawkins, Inc., a manufacturer, distributor, and blender of chemicals and ingredients, was 
incorporated in the state of Minnesota in 1938.  It was reincorporated in Minnesota in 1955 as 
Hawkins Chemical, Inc., and has been operating under the current name since 2001.  The firm 
went public in 1985.  Executive operations are based out of Roseville, Minnesota.  As of March 
31, 2019, Hawkins had 657 employees. 
Hawkins has a long history of acquisitions of existing companies and their assets.  In the 1970s 
and 1980s Hawkins acquired six companies: Vel-Tex Chemical (1971), The Lynde Co. (1972), 
Feed-Rite Controls, Inc. (1976), Mon-Dak Chemical Inc. (1979), Dakota Chemical, Inc. (1982), 
and Tessman Seed, Inc. (1989).  In 1993, Hawkins acquired Industrial Chemical & Equipment 
Co., which operated as the industrial segment of the Hawkins business. In 1998, Hawkins 
merged three of its subsidiaries to form the water treatment segment of their business.  Since 
2000, Hawkins has acquired certain assets from St. Mary’s Chemical (2000), all of the assets of 
Trumark, Inc. (2007), Advanced Chemical Solutions, Inc. (2013), The Dumont Company, Inc. 
(2014), and Davis Supply, Inc. (2015), as well as completing the total acquisition of Vertex 
Chemical Corporation (2011), Novel Wash Co. Inc. (2011), R.H.A. Corporation (2011), and 
Stauber Performance Ingredients (2015). 
Hawkins operates in three market segments:  industrial, water treatment, and health and nutrition.  
The largest of the three segments, the industrial segment, focuses on industrial chemicals, 
products, and services to the agricultural, chemical processing, electronics, energy, food, 
pharmaceutical, and plating industries.  The segment’s principal products are acids, alkalis, and 
industrial and food-grade salts.  Activities of the industrial group include receiving, storing and 
distributing various bulk chemicals, repackaging water treatment chemicals for its water 
treatment segment and bulk industrial chemicals for resale in smaller quantities, custom blending 
of chemicals for customers, and bleach packaging.  The segment’s products are sold in the food 
and pharmaceutical markets nationally.  The group’s sales are primarily focused in Illinois, Iowa, 
Kentucky, Minnesota, Missouri, North Carolina, North Dakota, South Dakota, Tennessee, and 
Wisconsin. 
The Hawkins water treatment segment provides chemicals, equipment and solutions for potable 
water, municipal and industrial wastewater, industrial process water, and non-residential 
swimming pool water.  The segment primarily services customers in Florida, Illinois, Iowa, 
Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota and Wisconsin. 
The health and nutrition segment is the smallest of the three segments.  This segment provides 
ingredient distribution, processing, and formulation solutions to manufacturers of nutraceutical, 
functional food and beverage, personal care, dietary supplement and other nutritional food, 
health, and wellness products.  The segment provides products such as minerals, botanicals and 
herbs, vitamins and amino acids, excipients, joint products, sweeteners and enzymes.  The 
segment’s wide range of products combined with services and solutions for its customer 
positions this segment as a one-stop ingredient solutions provider.  This segment’s products are 
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sold nationally, as well as internationally.  The segment operates facilities in California and New 
York. 
 
MANAGEMENT AND CORPORATE GOVERNANCE 
The executive leadership team of Hawkins, Inc. consists of the following members: 
Patrick Hawkins, Chief Executive Officer and President 
Hawkins joined the company in 1992 and has served as Business Director of  Food 
Pharmaceuticals, Business Manager of Food and Co-Extrusion Products, Sales 
Representative for Food Ingredients, Plant Manager, Quality Director, Technical 
Director, and various other positions.  He has been President since 2010 and CEO since 
2011.   
Jefffrey Oldenkamp, Vice President, Chief Financial Officer, Treasurer 
Oldenkamp joined the company in 2017 as Chief Financial Officer, and assumed the role 
of Vice President and Treasurer later that year.  Prior to working with Hawkins, he served 
as Vice President of Finance, and later Chief Financial Officer, at MTS Systems 
Corporation, a supplier of high-performance test systems and sensors, and served as 
Americas Operations Chief Financial Officer and Vice President with Nilfisk-Advance, 
Inc, a global manufacturer of professional cleaning equipment. 
Richard Erstad, Vice President, General Counsel, Secretary 
Erstad joined the company in 2008 as Vice President, General Counsel, and Secretary.  
Erstad is a member of the Minnesota BAR.  Prior to working with Hawkins, he served as 
General Counsel and Secretary of BUCA, Inc., a restaurant company and as an attorney 
with the corporate group of Faegre & Benson LLP, a law firm, where he focused on 
securities law, and mergers and acquisitions. 
Thomas Keller, Vice President – Water Treatment Group 
Keller joined the company in 1980, holding various positions, most recently as Water 
Treatment General Manager.  He has held his title as Vice President – Water Treatment 
Group since 2012. 
Shirley Rozeboom, Vice President – Health and Nutrition  
Rozeboom joined the company as a part of the Stauber acquisition in 2015.  At Stauber, 
she held positions as Senior Vice President of Sales, Director of Sales, and Account 
Executive.  She was named Vice President – Health and Nutrition in April 2019, 
replacing Daniel Stauber, who held this role through March 31, 2019. 
Incentive compensation across all executives is reliant in part to pre-tax income.  For executives 
in charge of a business unit, an operational measure of business profitability is a determinant in 
their incentive compensation.  Each executive also has individual determinants of their incentive 
compensation.  No incentive is paid unless 80 percent of each determinant is achieved.  The 
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Compensation Committee of the Board of Directors has discretion to adjust the final payouts of 
the program. 
For the Chief Executive Officer, Chief Financial Officer, and General Counsel, incentive 
compensation is based 80 percent on the corporate performance against the pre-tax income goal 
and 20 percent on meeting their individual goals.  The Chief Executive Officer’s individual 
determinants include overseeing strategic direction matters, business expansion matters, and 
operational efficiency initiatives.  Chief Financial Officer individual determinants include 
business efficiency and support, overseeing significant information technology initiatives, and 
talent management and engagement initiatives.  
For those executives in charge of a business unit, their incentive compensation is based 40 
percent on company-wide performance, 40 percent on business segment operational measure of 
business profitability, and 20 percent on individual objectives.  For the Vice President – Health 
and Nutrition, the business unit measure is based on the EBITDA performance of that segment 
and the individual determinants include business expansion initiatives.  The Vice President – 
Water Treatment Group has a business unit compensation that measure product sales less the 
cost of material including freight in and the selling costs as compared to a targeted level of 
operational profitability for the period.  Individual determinants for the Water Treatment Group 
include business expansion initiatives. 
There are additional annual equity incentive compensation programs available for executives that 
grant performance-based restricted stock units that would vest based on company performance 
during the current fiscal year and would be settled in share of restricted stock that would vest 
after two more years of service. 
The following table shows the members of the Board of Directors, their positions and 
experience: 
Board of Directors Positions Experience 
John S. McKeon Chairman of Board, 
Governance and Nominating 
Committee 
Retired President & CEO of 
ConAgra Foods, Inc. Venture 
Development Group 
Patrick Hawkins  Current Chief Executive 
Officer of Hawkins, Inc. 
Mary Schumacher Audit Committee, 
Compensation Committee 
Retired Chief Operating 
Officer of Twin Cities 
Habitat for Humanity 
Daniel Stauber  Retired Vice President of 
Health and Nutrition and 
President of Stauber 
Performance Ingredients, Inc. 
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Hawkins has low diversity in terms of gender; only one director is female.  Age diversity is 
moderate; all members (if their ages are provided) are between ages 48 and 77.   
Hawkins, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 3. The pillar scores are 
Audit: 1; Board: 5; Shareholder Rights: 2; Compensation: 4.  Corporate governance scores are 
from Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or 
region.  A score of 1 indicates low governance risk; a 10 indicates high governance risk. 
 
ACCOUNTING QUALITY AND POLICIES 
Hawkins, Inc. partners with the Minneapolis branch of KPMG for their auditing services.  
KPMG has been auditing Hawkins’ annual SEC filings since 2010.  KPMG issued an 
unqualified opinion on Hawkins’ 2019 financial statements.  In reviewing Note 1 to the financial 
statements regarding significant accounting policies, I found the following comments made by 
the auditors significant: 
• Hawkins inventory consists primarily of finished goods, valued at the lower of cost or net 
realizable value.  69 percent of the cost of inventory is determined using the last-in, first-
out (LIFO) method, and the other 31 percent is valued using first-in, first-out (FIFO). 
• There were no goodwill impairments found during the 2019 fiscal year.  In 2018, there 
was a goodwill impairment charge for USD 39.1 million related to the Health and 
Nutrition reporting unit.  The impairment was a result of changes in expectations for 
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future growth as part of long-term strategic planning to align historical experience with 
expected changes in future product mix. 
To determine if the accounting policies of Hawkins may be distorting the earnings of the 
company, I have calculated the quality of earnings ratio.  In 2019, the ratio is 1.83, and over the 
last five years, the ratio has averaged 1.78.  This quality of earnings ratio tells us that the net 
income for the firm is supported by appropriate operating cash flows. 
 
SHAREHOLDER ANALYSIS 
According to the Hawkins’ SEC quarterly filing, as of September 30, 2019, Hawkins has 
10,757,538 million shares outstanding. Institutional ownership is at 59.51 percent, with a total of 
6,349,717 shares held.  The top five institutional holders of the stock, reported as of June 19, 
2019, are as follows: 
Owner Name Shares Held  Percent held 
Blackrock Inc. 1,443,370 13.53% 
Vanguard Group Inc. 750,042 7.03% 
Price T. Rowe Associates Inc. 613,239 5.75% 
Dimensional Fund Advisors LP 612,234 5.74% 
State Street Corp 272,997 2.56% 
During the last twelve months, there have been 24 insider trades – 16 open market buys and 8 
sells.  On July 31, 2019, all directors acquired 1,144 shares, and on May 23, 2019, all officers 
acquired shares per their compensation packages.  All eight dispositions were made by Hawkins 
officers and are as follows: 
Insider Date Shares Sold 
Daniel Stauber 4/2/2019 365 
Thomas Keller 4/2/2019 1,163 
John Sevenich 4/2/2019 1,168 
Theresa Moran 4/2/2019 656 
Richard Erstad 4/2/2019 1,311 
Patrick Hawkins 4/2/2019 2,909 
Daniel Stauber 4/1/2019 995 
Thomas Keller 11/16/2018 100 
Hawkins, Inc. (HWKN) MSUM Paseka School of Business 11/1/2019 
P a g e  8 | 20 
 
On February 7, 2019, Hawkins announced that the Board of Directors increased the number of 
shares authorized to be repurchased under its share repurchase program by 500,000 shares of 
outstanding common stock.  The primary objective of the program is to offset the impact of 
dilution from issuances relating to employee and director equity grants and the company’s 
employee stock repurchase program.  Since the time of the announcement, the board has not 
stated a deadline for this stock repurchase. 
 
INDUSTRY ANALYSIS 
Hawkins, Inc. is a part of chemicals and allied products industry with the SIC 5169 and NAICS 
424690.  As listed on osha.gov, establishments in this industry are primarily engaged in the 
wholesale distributions of chemicals and allied products such as acids, industrial and heavy 
chemicals, dyestuffs, industrial salts rosin, and turpentine.   
The chemicals and allied products industry is large, with roughly 12,500 establishments that earn 
a combined USD 200 billion in annual revenue, per Dun & Bradstreet’s research.  Hawkins 
market share in this industry is roughly 0.27 percent.  According to the US Statistics of US 
Businesses (SUSB) 2016 census, there are 3,071 establishments with 500 or more employees – a 
similar operations size to Hawkins - in this NAICS code.  Each firm’s ability to compete within 
the industry is tied closely to product price, product performance, product quality, product 
availability and security of supply, breadth of product offerings, geographic reach, and ability to 
create product innovations, technical expertise and customer service. 
Product pricing and product availability can be challenges for the industry.  The commodities 
markets can be volatile and cyclical in nature, which can affect negatively a firm’s ability to 
price competitively and decrease their product profit margins. Contracts with suppliers are 
important in keeping product costs down, although that is not always a guarantee.   
Size and geographic reach contribute to the competitive nature of the industry.  Larger 
companies may be able to provide large product lines, secure better supply contracts, reach larger 
geographic areas, create larger distribution networks, and enjoy other economies of scale.  
Smaller, local or regional companies, like Hawkins, compete effectively by providing superior 
service and solutions or geographical focus.  Hawkins’ mission statement highlights this focus on 
customer services and solutions: “Our mission is to supply high quality products and innovative 
solutions with an exceptional level of customer service.” 
 
INVESTMENT RISK 
Hawkins Inc. deals with volatility in the price and availability of their products.  There are 
regular and reoccurring fluctuations in the pricing of raw materials such as caustic soda.  The 
cyclicality in raw materials commodities is a result of fluctuations in the supply of the material.  
There is always the added concern of long lead times, limits, or cutoffs in supply.  To help 
smooth out the cost of these raw materials, Hawkins has contracts with suppliers where prices 
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paid adjust quarterly or monthly. However, the prices paid under these contracts can lag behind 
the market prices of the raw materials.  This can lead to inventory values that exceed the current 
market pricing and puts product margins at risk.  
The chemicals and allied products industry need to comply with many local, state, and federal 
regulations.  Violation of any of these laws could lead to significant unexpected costs, loss of 
capacity to generate revenues, and increase the cost of doing business.  In their health and 
nutrition segment, Hawkins must abide by the Food and Drug Administration’s (FDA) 
regulations.  The risk of recalls and discontinuations of products, as well as the additional costs 
of required record-keeping, expanded documentation and labelling and additional scientific 
substantiation, are a relevant concern for this segment.  While there is the risk, there have been 
no disclosed recalls of any Hawkins products. 
The chemicals Hawkins handles can also be hazardous, toxic, or volatile under local, state, and 
federal law that pose a substantial environmental and safety risk.  Hazards common to chemical 
and allied products include explosions, fires, mechanical failures, traffic accidents, and 
environmental contamination.  Hawkins disclosed in their 2019 10-K that groundwater 
contamination does exist at one of their facilities, and they accrued USD 0.6 million for 








Sales    
in USD 
(million) 













Hawkins, Inc HWKN $549M $483M 17.67 9.07 0.44 6.33 12.06 
Innophos 
Holdings 
IPHS $759M $623M 29.79 9.06 0.59 4.89 6.30 
United Guardian, 
Inc. 
UG $12.9M $83M 20.34 16.13 0.13 23.49 37.76 
Univar Solutions UNVR $9.1B $4.35B 14.70** 11.18 0.77 4.36 -3.31 
Ashland Global 
Holdings, Inc 
ASH $3.7B $4.75B 47.53 11.41 0.58 2.67 2.45 
*The figures in this chart are as of November 9, 2019. Debt / Asset ratio is calculated using most recent 
audited financial statements. 
**Trailing P/E was not available.  Forward P/E was used here. 
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I chose the peers in this analysis because they share similar product lines with Hawkins, Inc., and 
they all operate in the same industry.   
Through its subsidiaries, Innophos Holdings produces specialty ingredient solutions for the food, 
health, nutrition, and industrial markets.  The company operates in three segments:  Food, Health 
and Nutrition; Industrial Specialties; and Co-Products and Other.  The company’s products have 
applications in the food, beverage and dietary supplement end markets.  
United Guardian manufactures and markets cosmetic ingredients, personal care products, 
pharmaceuticals, medical lubricants, health care products, and industrial products.  The company 
also takes part in R&D for cosmetic and personal care products.  United Guardian operates in 
one business segment with four separate product categories:  personal care products, 
pharmaceuticals, medical products, and industrial products.    
Univar Solutions is a chemical and ingredients distributor and provider of specialty services.  
The company purchases chemicals and warehouses, repackages, blends, dilutes, transports and 
sells those products to their customers.  They also provide value-added, specialty solutions 
including e-commerce and digital marketing and storage solutions for its customers.  The 
company operates in four geographical segments:  Univar USA, Univar Canada, Univar Europe 
and the Middle East and Africa, and Rest of World.   
Ashland Global Holdings provides specialty chemical solutions to customers in a range of 
consumer and industrial markets that include adhesives, architectural coatings, construction, 
energy, food and beverage, personal care and pharmaceutical.  The company operates within 
three segments: Specialty Ingredients, Composites and Intermediates, and Solvents.   
 
HISTORICAL FINANCIAL ANALYSIS 
I decided to compare Hawkins, Inc. with Innophos Holdings. They have a similar market 
capitalization and operate in similar segments.  Innophos’ segments include Food, Health and 
Nutrition, Industrial Specialties, and Other; the “Other” segment includes fertilizers and 
manufacturing products.  While there is a slight difference in the segments, there are no two 
companies in this industry that operate in identical segments.  Innophos has a fiscal year end of 
December 31 and Hawkins has a fiscal year end of March 31.  While Hawkins states that there is 
some cyclicality in the price and availability of their products, that factor would be too complex 
to take into account for purposes of this report.  For the purpose of this report, I consider the 
difference in timing of the reports immaterial. 
Productivity Ratios 
Hawkins has grown in sales over the last four reporting periods ranging from 4.3% to 16.8% per 
year.  Innophos generated positive sales growth during its most recent year and decreases in sales 
in the three of the last four years.  Hawkins has consistently had a higher inventory turnover ratio 
than Innophos, averaging about 8.58 times in the last five years over Innophos’ average of 3.9.  I 
partially attribute the difference to dissimilar operating segments.  Hawkins’ higher turnover has 
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translated into a higher operating working capital turnover as well.  Hawkins has maintained an 
average operating working capital turnover of over 5.26 for the last five years, while Innophos 
has averaged 3.86 over the same period.   
Hawkins’ assets are performing better that Innophos over this period.  Its operating working 
capital performance, long-term, and net fixed asset turnover perform above Innophos’. In three 
of the last five years, Hawkins has a higher invested capital turnover than Innophos.   
Productivity Ratios 
 2019 2018 2017 2016 2015 
HWKN Growth in sales 10.3% 4.3% 16.8% 13.7% N/A 
IPHS Growth in sales 11.1% -0.5% -8.1% -6.0% N/A 
HWKN Inventory turnover 8.49 7.72 9.17 7.98 8.55 
IPHS Inventory turnover 4.45 4.96 5.65 4.57 4.55 
HWKN Operating working capital turnover 5.49 5.43 6.28 4.26 4.84 
IPHS Operating working capital turnover 4.41 3.87 3.86 4.07 3.10 
HWKN Net fixed asset turnover 2.01 1.79 1.52 1.35 3.02 
IPHS Net fixed asset turnover 1.64 1.49 2.02 2.10 2.35 
HWKN Invested capital turnover 1.47 1.35 1.22 1.02 1.86 
IPHS Invested capital turnover 1.20 1.07 1.32 1.39 1.34 
*Innophos’ fiscal year end is December 31.  The data labelled 2019 is for their fiscal year ended December 
13, 2018. 
Liquidity Ratios 
Hawkins, Inc. and Innophos Holdings have similar current and quick ratios.  In the most recent 
reporting year, Hawkins had a current ratio of 2.54 while Innophos had 2.25 as their current 
ratio.  This is due to Innophos’ higher inventory as a percent of current assets; they increased 
their inventory in 2019 to support their transition to a value-chain business model.  In prior years, 
each company’s level of inventory held to support their business is the factor that determines 
who holds the higher current ratio.  Hawkins’s quick ratio was 1.49 and Innophos’s is 1.01 in the 
most recent reporting year.  In 2017 and 2018, Hawkins had a lower quick ratio because of lower 
cash reserves which was a result of increases in their debt repayments and capital expenditures 
after the acquisition of Stauber. The reason Innophos’s quick ratio fell in 2019 is that Innophos 
had a USD 10 million increase in their accounts payable due to an increase in customer demand. 
Hawkins average operating cycle for the last five years is 88 days and its cash cycle averages 66 
days over the same period.  This two are significantly lower than Innophos’.  Hawkins is able 
convert their products to cash from customers, on average, 25 days faster than Innophos is.  This 
could be a result of differing credit terms with vendors and customers. 
Liquidity Ratios 
 2019 2018 2017 2016 2015 
HWKN Current ratio 2.73 2.44 2.29 2.85 3.96 
IPHS Current ratio 2.25 2.64 2.98 2.82 3.90 
HWKN Quick ratio 1.49 1.31 1.31 1.80 2.56 
IPHS Quick ratio 1.01 1.36 1.63 1.16 1.90 
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HWKN Cash ratio 0.17 0.09 0.13 0.40 1.10 
IPHS Cash ratio 0.14 0.25 0.56 0.17 0.39 
HWKN Operating cycle 84.96 93.27 83.05 97.98 83.14 
IPHS Operating cycle 128.72 124.61 103.65 116.75 119.68 
HWKN Cash cycle 65.73 69.07 60.59 71.42 63.01 
IPHS Cash cycle 92.30 89.00 77.68 99.68 96.57 
*Innophos’ fiscal year end is December 31.  The data labelled 2019 is for their fiscal year ended December 
31, 2018. 
Financial Risk (Leverage) Ratios 
Hakwins uses less debt to finance their operations.  Hawkins’ debt to equity ratio has been 
decreasing for the last four years, from 1.09 to 0.65.  The increase in fiscal year 2016 was due to 
the capital needed for their acquisition of Stauber Performance Ingredients.  Since then, they 
have made it a point to decrease the financial debt they hold by increasing their debt repayments.  
Innophos’ debt to equity ratio has been increasing over the last three years from 0.55 to 1.43.  
During 2018, Innophos entered into a new credit agreement that increased their revolving credit 
from USD 400 million to USD 650 million, which they have been using to make their transition 
to the value-chain business model.  Due to the lower level of debt that Hawkins has, their interest 
expense is much lower than Innophos’.  This has allowed them to maintain a much higher 
interest coverage ratio – both accounting based and cash based.   
Financial Risk (Leverage) Ratios 
 2019 2018 2017 2016 2015 
HWKN Debt-to-equity ratio 0.65 0.80 0.83 1.09 0.27 
IPHS Debt-to-equity ratio 1.43 1.35 0.85 1.01 0.55 
HWKN Financial debt-to-equity ratio 0.35 0.45 0.45 0.63 0.03 
IPHS Financial debt-to-equity ratio 0.92 0.96 0.55 0.67 0.32 
HWKN Interest coverage ratio (accounting) 10.99 9.85 15.40 26.78 72.94 
IPHS Interest coverage ratio (accounting) 5.28 10.20 11.26 7.78 26.14 
HWKN Interest coverage ratio (cash) 15.24 14.21 18.06 33.46 89.30 
IPHS Interest coverage ratio (cash) 7.55 14.76 15.20 11.98 33.38 
HWKN Financial debt over total assets 0.21 0.25 0.25 0.30 0.03 
IPHS Financial debt over total assets 0.38 0.41 0.30 0.33 0.20 
*Innophos’ fiscal year end is December 31.  The data labelled 2019 is for their fiscal year ended December 
31, 2018. 
Profitability and Valuation Ratios 
In the last five fiscal years, Hawkins has had significantly lower gross profit, EBITDA, and 
NOPAT margins than Innophos’, with the exception of 2016 NOPAT margin.  Hawkin’s 2016 
NOPAT margin was an anomaly because the acquisition of Stauber Performance Ingredients 
included intangible assets that were deductible for income tax purposes, which allowed for 
Hawkins to record a USD 28.6 million deferred tax liability in that year.  Hawkins’ 2016 ROIC 
value of 27.33 percent is a result of the deferred tax liability.  Without the effect of this entry, all 
else held equal, the ROIC for Hawkins would be roughly 13 percent.  
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Both the return on equity ratio and return on assets ratios see a dramatic drop in 2018.  In fiscal 
2018, Hawkins saw a tax benefit as a result of the US Tax Cuts and Jobs Act of 2017, which 
lowered the tax rate to 21 percent for corporations.  In addition to the tax change, Hawkins also 
had a goodwill impairment charge for USD 39.1 million related to the Health and Nutrition 
reporting unit.  The impairment was a result of changes in expectations for future growth as part 
of long-term strategic planning to align historical experience with expected changes in future 
product mix.  Without the effect of the goodwill impairment, all else held equal, the return on 
assets for 2018 would be 8.6 percent, and return on equity would be 14.4 percent.   
Profitability/Valuation Ratios 
 2019 2018 2017 2016 2015 
HWKN Gross profit margin 21.1% 22.5% 24.0% 22.8% 23.2% 
IPHS Gross profit margin 23.5% 26.2% 25.9% 23.0% 26.9% 
HWKN EBITDA margin 10.5% 10.8% 11.9% 11.1% 13.6% 
IPHS EBITDA margin 12.7% 14.3% 16.1% 11.4% 17.3% 
HWKN NOPAT margin 5.6% 5.4% 7.1% 12.9% 11.5% 
IPHS NOPAT margin 8.1% 4.8% 8.3% 3.9% 10.7% 
HWKN Return on assets 6.9% 0.2% 7.3% 5.1% 15.7% 
IPHS Return on assets 8.3% 8.8% 13.0% 8.6% 15.8% 
HWKN Return on equity 11.4% 0.3% 13.3% 10.7% 14.1% 
IPHS Return on equity 13.3% 8.5% 15.0% 9.6% 15.2% 
HWKN Return on invested capital 8.40% 6.93% 8.43% 27.33% N/A 
IPHS Return on invested capital 9.23% 6.05% 10.34% 4.91% N/A 
*Innophos’ fiscal year end is December 31.  The data labelled 2019 is for their fiscal year ended December 
13, 2018. 
 
PROSPECTIVE FINANCIAL ANALYSIS 
Based on the quarterly data from the 2019, Hawkins has seen a slowing in sales over the last five 
quarters and their second quarter results saw a drop in sales of 3.63 percent over the same period 
in the prior year.  This appears to be a common theme in its competitors – Innophos Holdings, 
United Guardian, and Ashland Global have also seen slowing sales over the last five quarters.  
Into the future, I believe they will not achieve the same level of sales growth as 2019, given this 
trend, which led me to forecast only 9.5 percent growth rate for the fiscal year 2020.  I forecasted 
the long-term sales growth at 2 percent because the United States GDP is forecasted to be at 2 
percent or below into the future.  I performed a sensitivity analysis for the Hawkins stock price to 
change in sales growth and the weighted average cost of capital. 
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I forecasted the cost of goods sold to sales rate to be slightly lower than the five-year average due 
to statements made by management in their most recent quarterly report stating that pricing in 
the commodities market has been stable and they have negotiated better pricing in their vendor 
contracts.  I project selling, general and administrative expenses to be 11 percent in the future 
because this has been their consistent rate.  They have continually made it a focus to keep these 
expenses at a minimum, and without an expected increase in the sales rate into the future, these 
expenses should remain constant.  Depreciation over net property plant and equipment should 
stay constant into the future.  I expect no changes to their level of debt.  I forecast all other ratios 
to be the same as the most recent year.   
 
VALUATION AND INVESTMENT DECISION 
To derive a valuation price of USD 33.79, I used the corporate valuation model, which discounts 
expected free cash flows at the WACC.  Hawkins released its most recent financial statements on 
May 23, 2019. 
I also perform relative valuation using Innophos Holdings as the comparable company in the 
industry.  There is a wide range of estimates of price per share using the different multiples 
below.  The price/sales multiple and the market/book multiple yield the least extreme of the 
valuations, however both show different investment recommendations.  The price/earnings ratio 
provides a price per share of $80.44 because the earnings of Innophos are proportionally higher 
than Hawkins historical earnings.  The same can be said of the EV/EBITDA multiple.  




Price/Sales 0.60 $31.34 Overvalued Sell 
Price/Earnings 29.49 $80.44 Undervalued Buy 
EV/EBITDA 2.67 $13.59 Overvalued Sell 
Market/Book 1.86 $51.16 Undervalued Buy 
*IPHS ratios captured on November 24, 2019 
In discounting the free cash flows at the WACC, I arrived at the price of UDS 33.79, which is 
below the current price of USD 43.56.  The intrinsic value I calculated is more than 10 percent 
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below the current market price, and more than one standard deviation from the mean return.  
Based on this observation, I will suggest a SELL recommendation for this security until 
economic or market conditions change.  
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Hawkins Inc (NMS: HWKN)
In Thousands of USD
Income Statement 04/02/2017 04/01/2018 03/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024
Sales 483,593      504,169       556,326      609,177      657,911      697,386      725,281      739,787      
Costs of goods sold (COGS) 367,297      390,919       439,176      472,112      513,171      543,961      565,719      584,432      
Sales, general and administrative expense (SGA)58,844       58,895         58,640        67,009        72,370        76,712        79,781        81,377        
Depreciation 8,455          16,686         16,303        16,887        18,238        19,332        20,105        20,507        
Operating profit 48,997        37,669         42,207        53,169        54,133        57,381        59,676        53,471        
Interest expense 3,181          3,825          3,839          3,821          6,230          4,531          4,460          4,042          
Interest income -             -              -             -             -             -             -             -             
Nonoperating income (Expense) -             -              73              80              86              92              95              97              
Earnings before taxes (EBT) 45,816        33,844         38,441        49,427        47,989        52,941        55,311        49,526        
Tax expense 13,493        (5,899)         9,097          10,380        10,078        11,118        11,615        10,401        
Net income before extraordinary items 32,323        39,743         29,344        39,047        37,912        41,823        43,696        39,126        
After-tax extraordinary income (Expense) (168)           (39,116)       -             -             -             -             -             -             
Net income (NI) 32,155        627             29,344        39,047        37,912        41,823        43,696        39,126        
-             -              -             -             -             -             -             -             
Dividends-- preferred -             -              -             -             -             -             -             -             
Dividends-- common 8,683          9,161          11,975        13,214        14,581        16,089        17,754        19,590        
Additions to RE 23,472        (8,534)         17,369        25,834        23,331        25,734        25,942        19,536        
Balance Sheet 04/02/2017 04/01/2018 03/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024
Assets
Cash 6,861          4,990          9,199          10,073        10,879        11,531        11,993        12,233        
Inventory 52,735        65,322         65,526        71,751        77,491        82,141        85,426        87,135        
Accounts receivable 57,298        63,507         63,966        70,043        75,646        80,185        83,392        85,060        
Other short-term operating assets 5,511          6,749          5,762          6,309          6,814          7,223          7,512          7,662          
Short-term investments -             -              -             -             -             -             -             5,436          
Total current assets 122,405      140,568       144,453      158,176      170,830      181,080      188,323      197,525      
Net plant, property, & equipment (PPE) 121,540      123,826       118,628      129,898      140,289      148,707      154,655      157,748      
Other long-term operating assets 196,994      157,878       157,878      215,892      186,707      197,909      205,825      209,942      
Long-term investments 1,686          2,564          3,396          3,719          4,016          4,257          4,427          4,516          
Total assets 442,625      424,836       424,355      507,685      501,842      531,953      553,231      569,731      
-             -              -             -             -             -             -             -             
Liabilities and Equity -             -              -             -             -             -             -             -             
Accounts payable (AP) 29,756        33,424         29,314        32,099        34,667        36,747        38,217        38,981        
Accruals 14,445        13,103         12,483        13,669        14,762        15,648        16,274        16,600        
Other operating current liabilities 1,174          1,241          1,299          1,422          1,536          1,628          1,694          1,727          
All short-term debt 7,989          9,864          9,907          65,065        31,098        26,914        16,434        9,833          
Total current liabilities 53,364        57,632         53,003        112,255      82,064        80,937        72,618        67,140        
Long-term debt 100,594      96,408         79,974        74,915        72,889        75,926        77,838        79,373        
Deferred taxes 42,040        27,383         26,673        29,207        31,543        33,436        34,774        35,469        
Preferred stock -             -              -             -             -             -             -             -             
Other long-term liabilities 4,758          7,321          8,088          8,856          9,565          10,139        10,544        10,755        
Total liabilities 200,756      188,744       167,738      225,234      196,061      200,437      195,773      192,738      
Par plus PIC Less treasury (and other adjustments)182,715      185,472       188,628      188,628      188,628      188,628      188,628      188,628      
Retained earnings (RE) 59,154        50,620         67,989        93,823        117,153      142,887      168,830      188,365      
Total common equity 241,869      236,092       256,617      282,451      305,781      331,515      357,458      376,993      
Total liabilities and equity 442,625      424,836       424,355      507,685      501,842      531,953      553,231      569,731      
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Hawkins Inc (NMS: HWKN)
In Thousands of USD
Statement of Cash Flows 04/02/2017 04/01/2018 03/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024
Operating Activities
Net income 32,155        627             29,344        39,047        37,912        41,823        43,696        39,126        
Depreciation 8,455          16,686         16,303        16,887        18,238        19,332        20,105        20,507        
Change in deferred tax (202)           (14,657)       (710)           2,534          2,337          1,893          1,337          695             
-             -              -             -             -             -             -             -             
Change in inventory (878)           (12,587)       (204)           (6,225)         (5,740)         (4,649)         (3,286)         (1,709)         
Change in accounts receivable 1,973          (6,209)         (459)           (6,077)         (5,603)         (4,539)         (3,207)         (1,668)         
Change in other short-term operating assets 4,773          (1,238)         987             (547)           (505)           (409)           (289)           (150)           
Change in accounts payable (365)           3,668          (4,110)         2,785          2,568          2,080          1,470          764             
Change in accruals 1,432          (1,342)         (620)           1,186          1,094          886             626             325             
Change in other current liabilities 93              67               58              123             114             92              65              34              
Net cash from operating activities 47,436        (14,985)       40,589        49,713        50,413        56,509        60,517        57,926        
-             -              -             -             -             -             -             -             
Investing Activities -             -              -             -             -             -             -             -             
Investment in PPE (13,674)       (18,972)       (11,105)       (28,156)       (28,629)       (27,749)       (26,053)       (23,600)       
Investment in other long-term oper. ass. (6,033)         39,116         -             (58,014)       29,186        (11,202)       (7,916)         (4,117)         
Net cash from investing activities (19,707)       20,144         (11,105)       (86,171)       556             (38,952)       (33,970)       (27,717)       
-             -              -             -             -             -             -             -             
Financing Activities -             -              -             -             -             -             -             -             
Change in short-term investments -             -              -             -             -             -             -             (5,436)         
Change in long-term investments 538             (878)            (832)           (323)           (297)           (241)           (170)           (89)             
Change in short-term debt 2,500          1,875          43              55,158        (33,967)       (4,185)         (10,480)       (6,601)         
Change in long-term debt (29,304)       (4,186)         (16,434)       (5,059)         (2,027)         3,037          1,912          1,536          
Preferred dividends -             -              -             -             -             -             -             -             
Change in preferred stock -             -              -             -             -             -             -             -             
Change in other long-term liabilities (8,914)         2,563          767             768             709             574             406             211             
Change in common stock (Par + PIC) 2,981          2,757          3,156          -             -             -             -             -             
Common dividends (8,683)         (9,161)         (11,975)       (13,214)       (14,581)       (16,089)       (17,754)       (19,590)       
         Net cash from financing activities (40,882)       (7,030)         (25,275)       37,332        (50,163)       (16,904)       (26,086)       (29,969)       
-             -              -             -             -             -             -             -             
Net cash flow (13,153)       (1,871)         4,209          874             806             653             461             240             
Starting cash 20,014        6,861          4,990          9,199          10,073        10,879        11,531        11,993        
Ending cash 6,861          4,990          9,199          10,073        10,879        11,531        11,993        12,233        
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Hawkins Inc (NMS: HWKN)
Ratios 2019 2018 2017 2016 2015
Productivity Ratios
     Growth in sales 10.3% 4.3% 16.8% 13.7% N/A
     Receivables turnover 8.70            7.94            8.44            6.98            9.02            
     Inventory turnover 8.49            7.72            9.17            7.98            8.55            
     Operating working capital turnover 5.49            5.43            6.28            4.26            4.84            
     Net fixed asset turnover 1.57            1.40            1.52            1.35            3.02            
     Total asset turnover 1.11            1.00            1.09            0.92            1.41            
     Invested capital turnover 1.22            1.11            1.22            1.02            1.86            
Liquidity Ratios
     Current ratio 2.73            2.44            2.29            2.85            3.96            
     Quick ratio 1.49            1.31            1.31            1.80            2.56            
     Cash ratio 0.17            0.09            0.13            0.40            1.10            
     Short-tern investments over invested capital -            -              -             -             0.07            
     Operating Cycle 84.96          93.27          83.05          97.98          83.14          
     Cash Cycle 65.73          69.07          60.59          71.42          63.01          
Financial Risk (Leverage) Ratios
     Total debt-to-equity ratio 0.65            0.80            0.83            1.09            0.27            
     Total debt-to-equity ratio (excluding deferred taxes)0.55            0.68            0.66            0.90            0.21            
     Total financial debt-to-equity ratio 0.35            0.45            0.45            0.63            0.03            
     Interest coverage ratio (accounting-based)10.99          9.85            15.40          26.78          72.94          
     Interest coverage ratio (cash-based) 15.24          14.21          18.06          33.46          89.30          
     Total debt-to-assets ratio 0.40            0.44            0.45            0.52            0.21            
     Total financial debt over total assets 0.21            0.25            0.25            0.30            0.03            
     Long-term financial debt over invested capital0.21           0.26            0.25            0.32            0.03            
Profitability/Valuation Ratios
     Gross profit margin 21.06% 22.46% 24.05% 22.80% 23.17%
     EBITDA margin 10.52% 10.78% 11.88% 11.07% 13.62%
     Operating profit margin 7.59% 7.47% 10.13% 8.87% 11.12%
     NOPAT margin 5.64% 5.44% 7.05% 12.92% 11.46%
     Earnings before taxes margin 6.91% 6.71% 9.47% 8.54% 10.97%
     Net margin 5.27% 0.12% 6.65% 5.58% 7.88%
     Return on Assets 6.91% 0.15% 7.26% 5.13% 15.69%
     Return on Equity 11.43% 0.27% 13.29% 10.73% 14.10%
     Net investment rate 10.70% 179.98% -26.31% 390.26% 469.21%
     Dividend payout ratio 40.81% 1461.08% 27.00% 35.73% 27.40%
     ROIC 8.38% 6.93% 8.43% 27.33% N/A
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Hawkins Inc (NMS: HWKN)
Valuation 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026 3/31/2027 3/31/2028 3/31/2029
FCFs (34,375,792) 52,476,986 13,140,552 18,271,247 17,460,218 23,199,294 24,359,259 25,577,222 26,856,083 28,198,887
PV FCFs 40,767,144  (35,510,505) 694,633      4,423,793   8,118,933   11,677,502  10,801,014  10,462,089  10,133,799  9,815,811   
Value of Operations 546,560,928 540,003,423 572,231,421 602,036,370 635,156,418 665,319,981 696,857,781 729,827,275 764,287,850 800,300,837
Value of Investments 3,718,620 4,071,889 4,397,640 4,705,475 4,987,803 5,237,193 5,499,053 5,774,006 6,062,706 6,365,841
Value of Firm 572,776,299 566,302,152 600,182,424 631,521,995 666,287,612 697,942,115 731,039,887 765,641,377 801,809,069 839,607,505
`- Financial Debt 148,837,074 116,112,108 122,943,744 126,491,677 132,742,663 135,431,223 139,262,565 144,451,290 151,241,012 159,907,772
Implicit Value of Equity 423,939,225 450,190,044 477,238,680 505,030,319 533,544,949 562,510,892 591,777,322 621,190,087 650,568,057 679,699,733
Number of Shares Outstanding 10,654,887 10,654,887 10,654,887 10,654,887 10,654,887 10,654,887 10,654,887 10,654,887 10,654,887 10,654,887
Price per share 39.79$        42.25$         44.79$        47.40$        50.08$        52.79$        55.54$        58.30$        61.06$        63.79$        
